Synergistic Endoprosthesis System for Enhanced Vasculature Treatment

Publication ID: 24-11857444_0008_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Endoprosthesis System for Enhanced Vasculature Treatment,” Published Technical Disclosure No. 24-11857444_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857444_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,444.

Summary of the Inventive Concept

The present inventive concept integrates balloon expandable endoprostheses with distinct technologies such as AI, IoT, blockchain, and novel materials to create a more powerful system for treating vasculature, enabling real-time monitoring, optimization, and personalized treatment strategies.

Background and Problem Solved

The original patent disclosed balloon expandable endoprostheses for treating vasculature, but it lacked the ability to provide real-time monitoring and optimization, secure data management, and personalized treatment strategies. The present inventive concept addresses these limitations by combining the endoprosthesis with advanced technologies to create a more effective and efficient system.

Detailed Description of the Inventive Concept

The synergistic endoprosthesis system comprises a balloon expandable endoprosthesis integrated with a machine learning algorithm for real-time monitoring and optimization of the endoprosthesis deployment. The algorithm utilizes data from sensors embedded within the endoprosthesis to predict optimal deployment configurations. Additionally, the system includes a blockchain-based data management system to securely store and track patient-specific data and treatment outcomes. The system also features a network of IoT-enabled sensors disposed within the endoprosthesis and a cloud-based data analytics platform, which analyzes data from the sensors to predict potential complications and provide personalized recommendations for treatment. Furthermore, the endoprosthesis is made of a novel material with enhanced biocompatibility and durability, and is integrated with an AI-powered decision support system for guiding clinicians in selecting optimal treatment strategies.

Novelty and Inventive Step

The new claims introduce the integration of distinct technologies such as AI, IoT, blockchain, and novel materials with the balloon expandable endoprosthesis, which is not obvious from the original patent. The synergistic combination of these technologies provides a new and non-obvious solution for treating vasculature.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating the endoprosthesis with other advanced technologies such as robotics, virtual reality, or 3D printing. Additionally, the system could be adapted for use in other medical applications beyond vasculature treatment.

Potential Commercial Applications and Market

The synergistic endoprosthesis system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and peripheral vascular disease treatment. The system's ability to provide real-time monitoring, optimization, and personalized treatment strategies could revolutionize the treatment of vasculature diseases, offering a significant market opportunity.

CPC Classifications

Section	Class	Group
A	A61	A61F2/958
A	A61	A61F2/07
A	A61	A61M25/10
A	A61	A61F2/89
A	A61	A61F2002/072
A	A61	A61F2240/001
A	A61	A61F2240/008
A	A61	A61M2025/1004
A	A61	A61M2025/1068
A	A61	A61M2025/1075
A	A61	A61M2025/1084

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device engineering, specifically endovascular interventional technologies focusing on stent-graft systems, balloon expandable prostheses, and minimally invasive medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, expertise in medical device design, familiarity with interventional cardiology/vascular technologies, understanding of sensor integration, data analytics, and medical device regulatory requirements

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies like machine learning, IoT sensors, and data analytics into medical device design represents a predictable evolution of existing endoprosthesis technologies. The source patent's fundamental stent-graft design provides a clear technological foundation for incorporating advanced monitoring and optimization capabilities. These technological extensions represent incremental improvements using known techniques in medical device engineering.

Obvious Combinations & Variations

Source Patent Element

Balloon expandable stent-graft with multiple ringed stent elements

PTD Variation

Adding embedded sensors and machine learning algorithms for real-time deployment optimization

Obviousness Reasoning

Integrating sensors into medical devices is a known technique, and using machine learning for predictive analytics represents a standard approach to improving device performance and patient outcomes

Source Patent Element

Endoprosthesis delivery system with balloon assembly

PTD Variation

Implementing blockchain-based data management for tracking patient-specific treatment data

Obviousness Reasoning

Secure data tracking is a predictable technological extension for medical devices, particularly for personalized medical technologies

Source Patent Element

Stent-graft with inner and outer graft elements

PTD Variation

Incorporating novel biocompatible materials with enhanced durability and AI-powered decision support

Obviousness Reasoning

Material science improvements and AI integration represent standard design evolution in medical device engineering, offering incremental performance enhancements

Source Patent Element

Endoprosthesis with configurable deployment characteristics

PTD Variation

Adding IoT-enabled sensor networks for real-time complication prediction and personalized treatment recommendations

Obviousness Reasoning

Predictive monitoring technologies are a foreseeable advancement in medical device design, leveraging existing sensor and data analytics capabilities

Source Patent Element

Stent-graft system for vasculature treatment

PTD Variation

Creating secure API integration with electronic health records for comprehensive treatment planning

Obviousness Reasoning

Interoperability between medical devices and health information systems represents a standard technological progression in digital healthcare

35 U.S.C. § 103 Summary: Based on US Patent 11857444's disclosure of balloon expandable endoprosthesis technologies, the present publication demonstrates that integrating digital monitoring, data analytics, and advanced materials into medical device design represents an obvious technological progression for a person having ordinary skill in medical device engineering, thereby establishing prior art that would render similar claimed innovations non-patentable under standard obviousness analysis.

Original Patent Information

Patent Number	US 11,857,444
Title	Balloon expandable endoprosthesis
Assignee(s)	W. L. Gore & Associates, Inc.